Joanna Wiensch
Stock Analyst at Citigroup
(1.62)
# 2,231
Out of 4,433 analysts
24
Total ratings
70.59%
Success rate
7.95%
Average return
Main Sectors:
16 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Neutral | $260 → $282 | $236.62 | +19.18% | 3 | Aug 21, 2023 | |
| NVRO Nevro | Downgrades: Neutral | $40 | $11.17 | +258.10% | 1 | Jan 17, 2023 | |
| ABT Abbott Laboratories | Maintains: Buy | $117 → $114 | $104.87 | +8.71% | 6 | Oct 20, 2022 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $97.90 | -18.79% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Technologies | Initiates: Buy | n/a | $98.70 | - | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | n/a | $201.53 | - | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | n/a | $110.41 | - | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | n/a | $121.23 | - | 1 | Mar 5, 2020 | |
| DXCM DexCom | Initiates: Buy | n/a | $131.91 | - | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | n/a | $89.06 | - | 1 | Mar 5, 2020 | |
| SYK Stryker | Initiates: Buy | n/a | $333.98 | - | 1 | Mar 5, 2020 | |
| PODD Insulet | Initiates: Buy | n/a | $185.38 | - | 1 | Mar 5, 2020 | |
| EW Edwards Lifesciences | Initiates: Buy | n/a | $90.11 | - | 1 | Mar 5, 2020 | |
| BAX Baxter International | Initiates: Neutral | n/a | $35.17 | - | 1 | Mar 5, 2020 | |
| JNJ Johnson & Johnson | Initiates: Buy | n/a | $154.28 | - | 1 | Mar 5, 2020 | |
| MDT Medtronic | Initiates: Buy | n/a | $85.64 | - | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
Aug 21, 2023
Maintains: Neutral
Price Target: $260 → $282
Current: $236.62
Upside: +19.18%
Nevro
Jan 17, 2023
Downgrades: Neutral
Price Target: $40
Current: $11.17
Upside: +258.10%
Abbott Laboratories
Oct 20, 2022
Maintains: Buy
Price Target: $117 → $114
Current: $104.87
Upside: +8.71%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $97.90
Upside: -18.79%
iRhythm Technologies
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $98.70
Upside: -
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $201.53
Upside: -
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: n/a
Current: $110.41
Upside: -
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $121.23
Upside: -
DexCom
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $131.91
Upside: -
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: n/a
Current: $89.06
Upside: -
Stryker
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $333.98
Upside: -
Insulet
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $185.38
Upside: -
Edwards Lifesciences
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $90.11
Upside: -
Baxter International
Mar 5, 2020
Initiates: Neutral
Price Target: n/a
Current: $35.17
Upside: -
Johnson & Johnson
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $154.28
Upside: -
Medtronic
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $85.64
Upside: -